Neoadjuvant Inetetamab and Pertuzumab with Taxanes and Carboplatin (tcbip) in Locally Advanced HER2-positive Breast Cancer: a Prospective Cohort Study with Propensity-Matched Analysis
BMC Cancer(2024)
Key words
Inetetamab,Trastuzumab,HER2-positive breast cancer,Neoadjuvant,pCR
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined